Skip to main content

Iran imports more Sinopharm vaccines from China

Iran is finally making progress with its vaccination campaign against COVID-19, though virus cases are still rising.
AFP via Getty Images

Iran received millions of doses of China’s Sinopharm vaccine today.

The Red Cross Society of China sent six million doses of the vaccine against COVID-19 to Iran’s Ministry of Health via the Iranian Red Crescent Society. The Iranian health organization has now brought more than 106 million vaccine doses into the country, the official Islamic Republic News Agency reported.

Iran has been one of the world's most severely affected countries by the pandemic. There have been more than five million cases and more than 125,000 deaths in the country of 80 million. The government’s lockdowns have also severely affected the economy, which was already reeling from US sanctions and government mismanagement.

Iran’s vaccine rollout was repeatedly delayed earlier this year, but the country has made progress recently. Around 60% of the population has received at least one vaccine dose, according to the Oxford-based Our World in Data. In addition to vaccine imports, Iran has developed two vaccines domestically, one of them in conjunction with Cuba.

Despite the vaccination progress, Iran seems to be nearing a sixth wave of virus cases.

Sinopharm is widely used in the Middle East, though authorities in some countries have concerns about its effectiveness. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Already a Member? Sign in


The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.


What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial
What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

Text Alerts - Be the first to get breaking news, exclusives, and PRO content.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

We also offer team plans. Please send an email to and we'll onboard your team.

Already a Member? Sign in

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial